Modulatory role of asymmetric dimethylarginine (ADMA) in cannabinoid tolerance and dependence

Medical Hypotheses

Volumn 73, Issue 2, 2009, Pages 213-214

  Ulugol, Ahmet ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; OPIATE; TETRAHYDROCANNABINOL;

ANALGESIA; ARTICLE; CATALEPSY; CHRONIC PAIN; DRUG DEPENDENCE; DRUG TOLERANCE; HUMAN; HYPOTHERMIA; HYPOTHESIS; NOCICEPTION; OPIATE ADDICTION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ARGININE; CANNABINOIDS; DRUG TOLERANCE; HUMANS;

EID: 67349195381     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.02.013     Document Type: Article

References (27)

1. Fuentes J.A., Ruiz-Gayo M., Manzanares J., Vela G., Reche I., and Corchero J. Cannabinoids as potential new analgesics. Life Sci 65 (1999) 675-685
2. Pertwee R.G. Cannabinoid receptors and pain. Prog Neurobiol 63 (2001) 569-611
3. Walker J.M., and Huang S.M. Cannabinoid analgesia. Pharmacol Therapeut 95 (2002) 127-135
4. Banafshe H.R., Ghazi-Khansari M., and Dehpour A.R. The effect of cyclosporine on the development and expression of cannabinoid tolerance in mice. Pharmacol Biochem Behav 82 (2005) 658-663
5. Taylor D.A., and Fleming W.W. Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 297 (2001) 11-18
6. Kolesnikov Y.A., Pick C.G., and Pasternak G.W. NG-nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol 221 (1992) 399-400
7. Pasternak G.W., Kolesnikov Y.A., and Babey A.M. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance. Neuropsychopharmacol 13 (1995) 309-313
8. Bhargava H.N. Nitric oxide synthase inhibition blocks tolerance to the analgesic action of k-opiate receptor agonist in the rat. Pharmacology 52 (1996) 86-91
9. Kielstein A., Tsikas D., Galloway G.P., and Mendelson J.E. Asymmetric dimethylarginine (ADMA) - a modulator of nociception in opiate tolerance and addiction?. Nitric Oxide-Biol Ch 17 (2007) 55-59
10. Martin T.J., and Eisenach J.C. Pharmacology of opioid and nonopioid analgesics in chronic pain states. J Pharmacol Exp Ther 299 (2001) 811-817
11. Bhargava H.N. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behaviour. Pharmacol Rev 46 (1994) 293-324
12. Heinzen E.L., and Pollack G.M. The development of morphine antinociceptive tolerance in nitric oxide synthase-deficient mice. Biochem Pharmacol 67 (2004) 735-741
13. Koch T., and Höllt V. Role of receptor internalization in opioid tolerance and dependence. Pharmacol Therapeut 117 (2008) 199-206
14. Tappe-Theodor A., Agarwal N., Katona I., et al. A molecular basis of analgesic tolerance to cannabinoids. J Neurosci 27 15 (2007) 4165-4177
15. Garthweite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci 14 (1991) 60-67
16. Synder S.H., and Bredt D.S. Nitric oxide as a neuronal messenger. Trends Pharmacol Sci 12 (1991) 125-128
17. Babey A.M., Kolesnikov Y.A., Cheng J., Inturrisi C.E., Trifilletti R.R., and Pasternak G.W. Nitric oxide and opioid tolerance. Neuropharmacology 33 (1994) 1463-1470
18. Bhargava H.N., Cao Y.J., and Zhao G.M. Effect of 7-nitroindazole on tolerance to morphine, U-50, 488H and [D-Pen2, D-Pen5] enkephalin in mice. Peptides 18 (1997) 797-800
19. Devulder J.E. Could nitric oxide be an important mediator in opioid tolerance and morphine side effects?. J Clin Anesth 14 (2002) 81-82
20. Abdel-Zaher A.O., Hamdy M.M., Aly S.A., Abdel-Hady R.H., and Abdel-Rahman S. Attenuation of morphine tolerance and dependence by aminoguanidine in mice. Eur J Pharmacol 540 (2006) 60-66
21. Dambisya Y.D., and Lee T.-.L. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br J Pharmacol 117 (1996) 914-918
22. Homayoun H., Khavandgar S., Namiranian K., and Dehpour A.R. The effect of cyclosporine A on morphine tolerance and dependence: involvement of L-arginine/nitric oxide pathway. Eur J Pharmacol 452 (2002) 67-75
23. Thorat S.N., and Bhargava H.N. Effect of NMDA receptor blockade and NOS inhibition on the acute and chronic action of THC in mice. Brain Res 667 1 (1994) 77-82
24. Spina E., Trovati A., Parolaro D., and Giagnoni G. A role of nitric oxide in WIN 55, 212-2 tolerance in mice. Eur J Pharmacol 343 (1998) 157-163
25. Azad S.C., Marsicano G., Eberlein I., et al. Differential role of the nitric oxide pathway on the Δ9-THC-induced central nervous system effects in the mouse. Eur J Neurosci 13 (2001) 561-568
26. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthase. J Cardiovasc Pharmcol 20 (1992) S60-S62
27. Bode-Böger S.M., Scalera F., and Ignarro L.J. The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol Therapeut 114 (2007) 295-306